Transfer of Obligations. Pursuant to Title 21 CFR Part 312.52, Sponsor hereby transfers to Worldwide all of the obligations identified in Exhibit A attached hereto and incorporated by reference herein. Notwithstanding the foregoing, Sponsor will retain the ultimate authority and control over and responsibility for the Study. The Parties acknowledge and agree that Sponsor shall at all times be deemed to be the “sponsor” of the Study pursuant to the terms of the Federal Food, Drug and Cosmetic Act, as from time to time amended, and the regulations of the U.S. Food and Drug Administration (“FDA”), as promulgated in Title 21 of U.S. Code of Federal Regulations.
Appears in 3 contracts
Samples: Services Agreement (Neurotrope Bioscience, Inc.), Services Agreement (Neurotrope Bioscience, Inc.), Services Agreement (Neurotrope, Inc.)
Transfer of Obligations. Pursuant to Title 21 CFR Part 312.52, Sponsor hereby transfers to Worldwide WCT all of the obligations identified in Exhibit A attached hereto and incorporated by reference herein. Notwithstanding the foregoing, Sponsor will retain the ultimate authority and control over and responsibility for the Study. The Parties acknowledge and agree that Sponsor shall at all times be deemed to be the “sponsor” of the Study pursuant to the terms of the Federal Food, Drug and Cosmetic Act, as from time to time amended, and the regulations of the U.S. Food and Drug Administration (“FDA”), as promulgated in Title 21 of U.S. Code of Federal Regulations.
Appears in 2 contracts
Samples: Services Agreement (Synaptogenix, Inc.), Services Agreement (Neurotrope, Inc.)